Potential for reacquisition of cholera enterotoxin genes by attenuated Vibrio cholerae vaccine strain CVD 103-HgR
- PMID: 8132356
- PMCID: PMC186308
- DOI: 10.1128/iai.62.4.1480-1483.1994
Potential for reacquisition of cholera enterotoxin genes by attenuated Vibrio cholerae vaccine strain CVD 103-HgR
Abstract
The potential for reacquisition of ctxA genes by attenuated Vibrio cholerae O1 vaccine strain CVD 103-HgR was examined by performing a series of mating experiments under a variety of in vivo and in vitro conditions. We found no evidence that CVD 103-HgR could reacquire ctxA genes from wild-type V. cholerae O1 strains. However, if the donor V. cholerae O1 strains were genetically manipulated to add genes that allow chromosomal gene transfer, then ctxA sequences could be acquired by CVD 103-HgR. The minimal excretion of CVD 103-HgR by vaccinees and the refractoriness to reacquisition of ctxA sequences suggest that this well-tolerated, highly immunogenic live oral cholera vaccine will have a minimal environmental impact.
Similar articles
-
Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination.Infect Immun. 1999 Dec;67(12):6341-5. doi: 10.1128/IAI.67.12.6341-6345.1999. Infect Immun. 1999. PMID: 10569747 Free PMC article. Clinical Trial.
-
A review of the current status of enteric vaccines.P N G Med J. 1995 Dec;38(4):325-31. P N G Med J. 1995. PMID: 9522876 Review.
-
Construction of genetically marked Vibrio cholerae O1 vaccine strains.FEMS Microbiol Lett. 1993 Jul 15;111(1):15-21. doi: 10.1111/j.1574-6968.1993.tb06355.x. FEMS Microbiol Lett. 1993. PMID: 8359676
-
Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR.Lancet. 1988 Aug 27;2(8609):467-70. doi: 10.1016/s0140-6736(88)90120-1. Lancet. 1988. PMID: 2900401 Clinical Trial.
-
Biosafety aspects of the recombinant live oral Vibrio cholerae vaccine strain CVD 103-HgR.Vaccine. 2004 Jun 23;22(19):2457-69. doi: 10.1016/j.vaccine.2003.12.033. Vaccine. 2004. PMID: 15193410 Review.
Cited by
-
Acute, infectious diarrhea among children in developing countries.Semin Pediatr Infect Dis. 2004 Jul;15(3):155-68. doi: 10.1053/j.spid.2004.05.008. Semin Pediatr Infect Dis. 2004. PMID: 15480962 Free PMC article. Review. No abstract available.
-
Evaluation of a bivalent (CVD 103-HgR/CVD 111) live oral cholera vaccine in adult volunteers from the United States and Peru.Infect Immun. 1997 Sep;65(9):3852-6. doi: 10.1128/iai.65.9.3852-3856.1997. Infect Immun. 1997. PMID: 9284163 Free PMC article. Clinical Trial.
-
Immunogenicity and protective efficacy of a live, oral cholera vaccine formulation stored outside-the-cold-chain for 140 days.BMC Immunol. 2020 May 25;21(1):29. doi: 10.1186/s12865-020-00360-1. BMC Immunol. 2020. PMID: 32450807 Free PMC article.
-
Oral immunization with attenuated vaccine strains of Vibrio cholerae expressing a dodecapeptide repeat of the serine-rich Entamoeba histolytica protein fused to the cholera toxin B subunit induces systemic and mucosal antiamebic and anti-V. cholerae antibody responses in mice.Infect Immun. 1997 Aug;65(8):3118-25. doi: 10.1128/iai.65.8.3118-3125.1997. Infect Immun. 1997. PMID: 9234763 Free PMC article.
-
The sixth and seventh cholera pandemics are due to independent clones separately derived from environmental, nontoxigenic, non-O1 Vibrio cholerae.J Bacteriol. 1995 Jun;177(11):3191-8. doi: 10.1128/jb.177.11.3191-3198.1995. J Bacteriol. 1995. PMID: 7768818 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources